Literature DB >> 3875664

Parasite-monocyte interactions in human leishmaniasis: production of interleukin-1 in vitro.

G D Crawford, D J Wyler, C A Dinarello.   

Abstract

Leishmania are obligate intracellular protozoa that parasitize mononuclear phagocytes. Because mononuclear phagocytes are also the primary source of leukocytic pyrogen and of lymphocyte-activating factor, both considered properties of interleukin-1 (IL-1), we investigated in vitro production of leukocytic pyrogen and of lymphocyte-activating factor from human monocytes infected with Leishmania tropica. Despite parasitization of 95% of cells, 24- and 48-hr culture supernatants and cell lysates derived from L. tropica-infected monocytes did not contain IL-1. Leishmania that were killed by freezing or by glutaraldehyde treatment similarly did not induce monocyte production of IL-1. Of importance is the observation that human monocytes infected with L. tropica for 6 hr and then challenged with a potent IL-1 inducer (Staphylococcus epidermidis) produced significantly less IL-1 than did uninfected monocytes that were similarly challenged (P less than .001). This difference was not affected by the addition of indomethacin to the cultures. In contrast, soluble immune complexes prepared with an excess of L. tropica antigen and rabbit antibody to L. tropica induced high levels of IL-1 production from normal monocytes. Neither antigen nor antibody alone incubated with monocytes led to significant production of IL-1, however. Thus, these studies suggest that despite leishmanial adherence to, entrance into, and replication within human monocytes there is little or no stimulation of IL-1 production. This may represent a parasite evasion mechanism that retards the development of protective immune responses in leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875664     DOI: 10.1093/infdis/152.2.315

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

Authors:  N E Reiner; W Ng; C B Wilson; W R McMaster; S K Burchett
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

2.  Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence.

Authors:  D E Hatzigeorgiou; J Geng; B Zhu; Y Zhang; K Liu; W N Rom; M J Fenton; S J Turco; J L Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Functional and phenotypic changes in human lymphocytes after coincubation with Leishmania donovani in vitro.

Authors:  L Hviid; A L Sørensen; A Kharazmi; T G Theander
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.

Authors:  J van Lunzen; P Kern; J Schmitz; J Brzoska; S Flessenkämper; M Dietrich
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

5.  PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.

Authors:  Marina Tiemi Shio; Jan Gregor Christian; Jee Yong Jung; Kwang-Poo Chang; Martin Olivier
Journal:  PLoS Negl Trop Dis       Date:  2015-06-26

6.  Identification of Leishmania genes encoding proteins containing tandemly repeating peptides.

Authors:  A E Wallis; W R McMaster
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.